Plain-English translation of NCT06427421 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying specific immune cells called regulatory T cells to understand what goes wrong in type 1 diabetes. By comparing blood samples from children newly diagnosed with diabetes to healthy children, they hope to identify which immune cells stop working properly and how that leads to diabetes developing. This knowledge could eventually help create new treatments to restore the body's natural ability to protect its insulin-producing cells.
Type 1 diabetes happens because the immune system mistakenly attacks cells that make insulin. Scientists believe that certain protective immune cells (called regulatory T cells) fail to do their job properly in children with diabetes. Understanding exactly how and why these cells malfunction could lead to new therapies that might prevent or even reverse type 1 diabetes.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate one blood sample at a hospital or clinic. The researchers will use numbing cream to make the needle stick less uncomfortable. Your blood will be analyzed in the laboratory to study your immune cells in detail. The entire visit should take less than an hour, and there is no ongoing treatment or follow-up required after the blood draw.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France